BSE Live
Dec 03, 16:02Prev. Close
353.50
Open Price
354.30
Bid Price (Qty.)
349.30 (25)
Offer Price (Qty.)
352.95 (1)
NSE Live
Dec 03, 15:54Prev. Close
353.95
Open Price
353.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
350.35 (197)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -135.97 | 37.18 | -61.23 | -84.04 | 1.40 | |
| Net CashFlow From Operating Activities | -82.86 | 107.16 | 172.06 | 103.84 | 97.85 | |
| Net Cash Used In Investing Activities | -18.52 | -8.33 | -2.73 | -17.92 | 22.74 | |
| Net Cash Used From Financing Activities | 109.39 | -98.45 | -163.67 | -91.06 | -128.69 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 8.02 | 0.37 | 5.66 | -5.15 | -8.09 | |
| Cash And Cash Equivalents Begin of Year | 6.90 | 4.59 | 0.86 | 6.01 | 14.13 | |
| Cash And Cash Equivalents End Of Year | 14.92 | 4.96 | 6.52 | 0.86 | 6.04 |
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y